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Abstract
Gene inactivation through RNA interference (RNAi) has proven to be a valuable tool for studying gene function in C. elegans.
When combined with tissue-specific gene inactivation methods, RNAi has the potential to shed light on the function of a
gene in distinct tissues. In this study we characterized C. elegans rrf-1 mutants to determine their ability to process RNAi in
various tissues. These mutants have been widely used in RNAi studies to assess the function of genes specifically in the C.
elegans germline. Upon closer analysis, we found that two rrf-1 mutants carrying different loss-of-function alleles were
capable of processing RNAi targeting several somatically expressed genes. Specifically, we observed that the intestine was
able to process RNAi triggers efficiently, whereas cells in the hypodermis showed partial susceptibility to RNAi in rrf-1
mutants. Other somatic tissues in rrf-1 mutants, such as the muscles and the somatic gonad, appeared resistant to RNAi. In
addition to these observations, we found that the rrf-1(pk1417) mutation induced the expression of several transgenic
arrays, including the FOXO transcription factor DAF-16. Unexpectedly, rrf-1(pk1417) mutants showed increased endogenous
expression of the DAF-16 target gene sod-3; however, the lifespan and thermo-tolerance of rrf-1(pk1417) mutants were
similar to those of wild-type animals. In sum, these data show that rrf-1 mutants display several phenotypes not previously
appreciated, including broader tissue-specific RNAi-processing capabilities, and our results underscore the need for careful
characterization of tissue-specific RNAi tools.
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Introduction
Double-stranded (ds) RNA-induced gene silencing, also called
RNA interference (RNAi), was initially discovered in the
nematode Caenorhabditis elegans as a defense mechanism against
viruses and transposable elements. Since then, RNAi has proven to
be a powerful experimental tool to gain insight into gene function
in multiple organisms [1]. During RNAi in C. elegans, dsRNA
serves as a trigger for sequence-specific degradation of mRNA as a
mechanism of gene silencing [2,3]. The dsRNA is first cleaved into
short-interfering (si) RNAs by a complex containing Dicer, an
RNase III family endoribonuclease. These siRNAs are then loaded
into the RNA-induced silencing complex (RISC) where they guide
recognition of the target-complementary mRNA, which is
subsequently cleaved and degraded. Intriguingly, only a few
molecules of dsRNA are sufficient to direct degradation of a much
larger population of mRNAs [4,5]. This is due to an amplification
process mediated by RNA-dependent RNA polymerases (RdRPs).
The RdRPs use siRNAs derived from Dicer-complex processing as
primers to produce more dsRNA, with the mature endogenous
mRNA as a template. These newly synthesized dsRNA molecules
may also feed back into the Dicer complex to be cleaved into
additional siRNA (for review, see [4,5]).
In C. elegans, four RdRP homologs have been identified to date:
EGO-1 and RRF-1, -2, and -3. EGO-1 and RRF-1 have been
implicated in the amplification of exogenous RNAi [6,7], whereas
RRF-3 is required for the production and/or stabilization of a
subset of endogenous siRNAs [7,8]. So far, no clear function has
been attributed to the fourth member of the RdRPs, RRF-2. As
regulators of the exogenous RNAi pathway, deletion of EGO-1
and RRF-1 leads to RNAi resistance, whereas deletion of RRF-3
results in an increased response to exogenous RNAi, likely due to
the reduced competition for resources between the endogenous
and exogenous RNAi pathways [8]. Importantly, EGO-1 and
RRF-1 have tissue-specific RNAi-processing capabilities. ego-1
mutants are only partially sensitive to RNAi directed against genes
expressed in the germline, but appear fully sensitive to the
inactivation of at least one gene, the Notch ligand LAG-2,
expressed in the somatic gonad. Moreover, EGO-1 is required for
germline development, and is reported to be primarily germline-
specific [6]. Based on these findings, the current hypothesis is that
EGO-1 is required for the RNAi response targeting germline-
specific genes. In contrast, RRF-1 is thought to be required for
amplification of the dsRNA signal in the somatic tissues [7]. The
known rrf-1 deletion mutants are viable, fertile, and indistinguish-
able from wild-type animals. These mutants are sensitive to RNAi
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resistant to muscle-specific RNAi triggers [7]. Based on these
RNAi experiments, the rrf-1 mutant strain has become the most
widely used tool in the C. elegans field for determining the site of
action of genes specifically in the germline. As an illustration, close
to 50 publications to date have used the rrf-1(pk1417) allele to
conclude that a gene of interest functions in the germline and not
in the soma. The initial analysis of the rrf-1 strain examined
muscle-expressed genes as examples of somatic gene expression,
and different genes predominantly expressed in the germline [7].
Here, we describe an analysis of somatic tissues besides muscles in
which rrf-1 could function.
Key advantages of using C. elegans as a model organism for
genetic studies is its experimental tractability while displaying
physiological complexity with multiple specialized tissues. The
study of tissue-specific functions of genes using RNAi techniques
requires robust tissue-selective tools. To address whether the rrf-1
mutant is an efficient tool for probing the function of genes
specifically in the germline, we have characterized the effect of
rrf-1 mutations on processing RNAi in various specialized tissues in
C. elegans. We confirmed that rrf-1 mutants are able to process
RNAi efficiently in the germline, and are resistant to RNAi in the
muscle, as reported previously [7]. However, we found that rrf-1
mutants are capable of processing RNAi in the intestinal soma
against several endogenous genes as well as GFP reporters
expressed in the intestine. We also used transgenic reporters to
assess the RNAi-processing capabilities of other somatic tissues in
rrf-1 mutants, and found that transgene reduction occurred in a
subset of hypodermal cells, the seam cells, whereas the somatic
gonad was resistant to gfp RNAi. In contrast, the hypodermis was
resistant to RNAi against at least two endogenous targets,
suggesting that this somatic tissue may be able to process RNAi
in some, but not all, cells. Taken together, these results show that
the rrf-1 mutants are sensitive to at least some RNAi triggers in
somatic tissues, most notably in the intestine. In addition to
imparting an ability to process somatic RNAi, we found that the
rrf-1(pk1417) mutation also increased the expression of some
transgenes in somatic tissues. Lastly, we discovered that the rrf-1
mutant displayed increased endogenous expression of the FOXO
transcription factor DAF-16 target gene sod-3, a superoxide
dismutase, suggesting that rrf-1 mutants may have increased
DAF-16 activity. While DAF-16 is a key modulator of C. elegans
longevity, the possible increase in its activity in rrf-1 mutants does
not translate into an extended lifespan or increased stress
resistance. Our characterization of the rrf-1 mutant highlights
the need for researchers to exercise caution in using this mutant as
a tissue-specific RNAi tool, including in the study of longevity
pathways with relevance to the FOXO transcription factor DAF-
16.
Results
RNAi is Processed in the Intestine of Two Different rrf-1
Mutants
Because we were interested in using the C. elegans rrf-1 strain as a
tool for tissue-specific RNAi experiments, we sought to charac-
terize the potency of RNAi in various tissues in this mutant. To
this end, we employed two different strategies. In the first, we
selected several RNAi clones reported to be exclusively or
primarily expressed in specific tissues and monitored their
corresponding tissue-specific phenotypes in C. elegans. We tested
these RNAi clones for effects in two different rrf-1 loss-of-function
alleles; rrf-1(pk1417) and rrf-1(ok589) [7]. The pk1417 allele
contains a large deletion that removes 400 amino acids in the
RRF-1 protein, including most of the conserved RdRP-specific
residues [7]. The ok589 allele similarly contains a 303-amino acid
deletion in RRF-1, which is also presumed to be a null mutation.
As a complementary approach, we crossed several transgenic
strains with different tissue-specific GFP expression with the
rrf-1(pk1417) loss-of-function mutant, and initiated RNAi by
feeding these new strains bacteria expressing gfp dsRNA. Using
these two approaches, we initially reexamined the two tissues that
previously had been investigated in rrf-1 mutants, namely the
germline and body-wall muscle [7]. As expected, we found that
both rrf-1 mutants were capable of processing endogenous and gfp
RNAi triggers in the germline (Figure S1) but not in the muscles
(Figure S2), as shown in [7].
We next tested the ability of the rrf-1 strain to process RNAi in
the intestine. The intestine is the tissue that takes up dsRNA when
delivered by ingestion of bacteria, and might therefore be
especially sensitive to RNAi by feeding. To test this, we searched
for genes that were expressed only in the intestine, and would
induce an easily detectable intestinal phenotype upon RNAi-
mediated silencing. The GATA-type transcription factor ELT-
2 fit these criteria as it is expressed exclusively in the intestine,
where it is required for intestinal differentiation [9]. Accordingly,
the elt-2 mutation is known to cause lethality at the L1 stage, with
animals displaying a blocked intestinal lumen [9,10]. Consistent
with a role for elt-2 in the intestine, we found that wild-type C.
elegans and rrf-3(pk1426) mutants (which display enhanced somatic
RNAi sensitivity due to a loss-of-function mutation in the RdRP
RRF-3 [8]), both experienced constricted and occluded intestines
and a clear appearance when subjected to elt-2 RNAi (Figure 1).
Moreover, we found that rde-1(ne219) mutants (which are resistant
to RNAi due to a loss-of-function mutation in the Argonaut
protein RDE-1, a key component of the RISC complex [11])
expressing RDE-1 under the intestinal nhx-2 promoter [12],
responded to elt-2 RNAi similarly to the wild-type animals
(Figure 1). As expected, a strain expressing RDE-1 in the
hypodermis (rde-1(ne219); lin-26p::rde-1) was unaffected by elt-2
RNAi [13] (Figure 1). Notably, when we subjected either
rrf-1(pk1417) or rrf-1(ok589) mutants to elt-2 RNAi, we observed
comparable phenotypes to those observed in wild-type animals
grown on bacteria expressing elt-2 dsRNA (Figure 1), implying
that rrf-1 mutants are capable of processing elt-2 RNAi.
We also investigated a second intestinal gene, pept-1, which
encodes an oligopeptide transporter expressed in the apical
membrane of the intestine. Inactivation of pept-1 abolishes the
uptake of peptides into the gut lumen, delays development, and
reduces body and brood size [14]. When we subjected wild-type or
rrf-3(pk1426) animals to pept-1 RNAi, they displayed a clear body
appearance indicative of reduced intestinal fat content [15]
(Figure S3A), as well as a reduced size (Figure S3B). Similar
phenotypes were observed in the intestinally rescued rde-1 strain,
as well as in the hypodermally rescued rde-1 strain (Figure S3),
suggesting that pept-1 may be expressed not only in the intestine
but also in the hypodermis. Importantly, when rrf-1(pk1417) and
rrf-1(ok589) mutants were subjected to pept-1 RNAi, they also
displayed a clear appearance (Figure S3A), and a smaller body
size (Figure S3B), consistent with rrf-1 mutants being at least
partially capable of processing pept-1 RNAi in somatic tissues such
as the intestine. Collectively, our analysis of endogenous genes
indicated that the intestine is capable of processing RNAi in rrf-1
mutants.
Somatic RNAi Effects in C. elegans rrf-1 Mutants
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Mutants Expressing Different GFP Reporters
To further investigate the finding that rrf-1 mutants can process
RNAi in the intestine, we employed two different transgenic
strains with strong GFP expression in the intestine. The first strain
overexpresses a GFP-tagged version of the protein LGG-1, a
homolog of the mammalian protein LC3, with prominent
expression observed in the intestine, pharynx, hypodermis, and
somatic gonad [16]. When we fed bacteria expressing gfp dsRNA
to an rrf-1(pk1417) strain carrying the lgg-1 reporter, we observed a
strong reduction in intestinal GFP that was readily apparent by
day 1–2 of adulthood (Figure 2A). To exclude the possibility that
GFP silencing depended on the lgg-1 transgene, we used a second
reporter strain with strong intestinal GFP fluorescence. This strain
expresses the FOXO transcription factor DAF-16 with an N-
terminal GFP tag, under the control of the daf-16 promoter [17].
When we subjected the rrf-1(pk1417) strain carrying the daf-16
reporter construct to gfp RNAi, this treatment resulted in a
noticeable albeit partial loss of intestinal GFP expression
compared to wild-type animals (Figure 2B). Taken together,
our results demonstrate that C. elegans rrf-1 mutants are at least
partially capable of processing RNAi in the intestinal soma.
The Hypodermis of rrf-1 Mutants shows Mixed
Susceptibility to RNAi
To determine if other somatic tissues were able to process RNAi
in rrf-1 mutants, we next investigated the hypodermis, a tissue
comprised of multiple cell types that establish the basic body form
and which secretes the cuticle of the animal. We tested RNAi
processing in the hypodermis by inhibiting different genes that are
reported to be exclusively or primarily expressed in the
hypodermis. The dual oxidase BLI-3 generates hydrogen peroxide
required for the crosslinking of collagen dityrosines during cuticle
formation [18]. RNAi-induced reduction of the bli-3 gene,
reported to be expressed exclusively in the hypodermis, led to an
extreme molting defect in the rrf-3(pk1426) strain, in wild-type
animals as well as in hypodermally rescued rde-1 mutants
(Figure 3A). Interestingly, the intestinally rescued rde-1 mutant
was similarly affected by bli-3 dsRNA, suggesting that bli-3 may be
more broadly expressed than reported. Importantly, we observed
that the rrf-1(pk1417) and rrf-1(ok589) strains were largely
unaffected by bli-3 RNAi (Figure 3A and Figure S4A), even
when treated for multiple generations (data not shown). The rrf-1
strains were similarly resistant to RNAi against another gene
reported to be expressed exclusively in the hypodermis, the
membrane protein tetraspanin encoded by tsp-15 [19]. We found
that rrf-1 mutants subjected to tsp-15 RNAi were resistant to blister
formation and defects in body morphology, whereas tsp-15 RNAi-
treated wild-type animals were severely affected (data not shown).
Figure 1. Intestinal elt-2 RNAi induces prominent phenotypes in rrf-1 mutants. The indicated C. elegans strains were raised on bacteria
expressing elt-2 dsRNA and imaged by DIC microscopy on day 3 of adulthood. The rde-1 strain and the rde-1 strain expressing RDE-1 in the
hypodermis (lin-26p::rde-1) were unaffected by RNAi, whereas all other strains tested show growth defects, a clear appearance, and an abnormal
intestine. This experiment was repeated four times with ,100 worms per strain with similar results. WT: wild-type N2 (A – Hansen lab, B – Tuck lab),
rrf-1(pk1417).4x: rrf-1(pk1417) outcrossed 4 times to WT(A).
doi:10.1371/journal.pone.0035428.g001
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other genes that are largely expressed in the hypodermis, bli-4
(subtilisin-like serine endoprotease) and die-1 (zinc finger protein),
induced comparable phenotypes in rrf-1 mutants and wild-type
animals (Figure S4A, B). However, the interpretation of these
results was compromised by the fact that bli-4 and die-1 are not
exclusively expressed in the hypodermis, but are also present in
other somatic tissues including the intestine. Consistent with this
notion, we found that both bli-4 and die-1 RNAi induced
phenotypes in both hypodermally and intestinally rescued rde-1
strains (Figure S4B and data not shown). Taken together, our
analysis of endogenous genes does not support an RNAi-
processing ability of the hypodermis.
To extend these findings, we analyzed RNAi processing in seam
cells, a specialized hypodermal cell type important for the
formation of cuticular structures called alae. For these studies,
we introduced a seam cell-specific GFP reporter into the
rrf-1(pk1417) mutant and compared the GFP signal in these
mutants and wild-type animals after they had been fed from
hatching with bacteria expressing gfp dsRNA. Interestingly, we
Figure 2. GFP reporters in the intestine of rrf-1 mutants are repressed by gfp RNAi. The indicated C. elegans strains were raised on bacteria
expressing gfp dsRNA, and imaged by DIC and fluorescence microscopy (overlays shown here) on day 1 of adulthood. rrf-1 mutants carried the
pk1417 allele. (A) The lgg-1p::gfp::lgg-1 reporter is expressed in the intestine, pharynx, somatic gonad, and hypodermis. GFP expression is dramatically
reduced upon treatment with gfp RNAi in both wild-type and rrf-1 animals. The exposure time for the GFP channel under control conditions was
15 ms and for gfp RNAi 25 ms. In the gfp RNAi micrographs, note that the pharynx appears largely unaffected by RNAi in both wild-type and in rrf-1
animals. See Figure S5B, D for additional information on transgene intensity. (B) The daf-16p::gfp::daf-16 reporter is expressed in the intestine, and
GFP expression is abolished in the wild-type and reduced in the rrf-1 background. The rrf-1 mutant shows visibly higher transgene expression levels
compared to the wild-type strain. The exposure time for the GFP channel was 200 ms. See Figure S7A, B for additional information on transgene
intensity. These experiments were repeated 2–3 times with 30–50 worms per strain and imaging of ,10 per experiment, with similar results.
doi:10.1371/journal.pone.0035428.g002
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e35428Figure 3. rrf-1 mutants are resistant to RNAi against the hypodermal gene bli-3, but are able to process gfp RNAi in seam cells. The
indicated C. elegans strains were raised on bacteria expressing bli-3 dsRNA (A) and gfp dsRNA (B) and imaged by bright-field or fluorescence
microscopy, respectively, on day 1 of adulthood. (A) The rrf-1 mutants, as well as the RNAi-resistant rde-1 strain are unaffected by bli-3 RNAi, whereas
all other strains tested show severe molting defects and varying degrees of blister formation. See Figure S4A for additional information. This
experiment was repeated three times with 100–200 worms per strain with similar results, also for several generations. WT: wild-type N2 (A – Hansen
lab, B – Tuck lab), rrf-1(pk1417).4x: rrf-1(pk1417) outcrossed 4 times to WT(A). (B) The SCMp::gfp reporter is exclusively expressed in hypodermal seam
cells, which are denoted with arrows. GFP expression is abolished in the wild-type background and reduced in the rrf-1(pk1417) background. The rrf-1
mutant shows visibly higher GFP expression levels compared to the wild-type strain. The exposure time for the GFP channel was 100 ms. See Figure
S4C for quantification of transgene intensity. These experiments were repeated 3 times with 30–50 worms per strain and imaging of ,10 per
experiment, with similar results.
doi:10.1371/journal.pone.0035428.g003
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had a significantly reduced GFP signal in their seam cells in
response to gfp RNAi (Figure 3B and Figure S4C). Thus, in our
transgenic analysis we observed that hypodermal seam cells were
at least partially capable of processing gfp RNAi, which was in
contrast to the results we obtained when analyzing endogenous
genes exclusively expressed in the hypodermis. Taken together,
these experiments highlight the possibility that a restricted subset
of cells in the hypodermis is able to process RNAi.
The Somatic Gonad is Resistant to RNAi in rrf-1(pk1417)
Mutants
Because the rrf-1(pk1417) mutant has been used in many studies
to determine whether a gonadal gene functions in the germline or
in the somatic gonad, we were specifically interested in determin-
ing if the somatic gonad of rrf-1 mutants was able to process RNAi.
To do this, we examined the persistence of GFP expression after
feeding gfp RNAi to the rrf-1(pk1417) strain carrying a lag-2p::gfp
transcriptional reporter strain that displays GFP fluorescence in
the distal tip cell (DTC) [20]. In the rrf-1 background, the GFP
signal in the DTC persisted upon treatment with gfp RNAi, which
is consistent with previous reports that somatic tissues of rrf-1
mutants are resistant to RNAi (Figure S5A). Moreover, GFP
fluorescence was maintained in the spermatheca and vulva when
rrf-1(pk1417) animals expressing the lgg-1p::gfp::lgg-1 reporter were
treated with gfp RNAi (Figure S5B). Taken together, these results
indicate that the somatic gonad may be resistant to RNAi in rrf-1
mutants.
Somatic RNAi Effects in rrf-1(pk1417) Mutants are not Due
to the Negative RNAi Regulator ERI-6/7
It is possible that the ability of rrf-1 mutants to process RNAi in
at least some somatic tissues is not an intrinsic feature of the rrf-1
mutation, but instead could be due to mutations in negative
regulators of the RNAi pathway in that strain [4]. For example,
disruption of the adjacent genes eri-6 and eri-7 can lead to an
enhanced RNAi response [4]. To exclude the possibility that
known eri-6/eri-7 background mutations have accumulated in the
rrf-1strains used in this study, we amplified and sequenced the
eri-6/eri-7 locus. Neither of the two rrf-1 alleles carried the
mutation mg441 (data not shown), a mutation that leads to an
enhanced RNAi response due to erroneous splicing and genomic
rearrangements in the eri-6/7 locus (Figure S6) [4]. In addition,
we designed primers flanking three other reported deletion
mutations (tm1887, tm1716, tm1917), and found no evidence that
the rrf-1 strains used in this study harbored any of these reported
eri-6/7 mutations (Figure S6). While this analysis does not
exclude the possibility that unidentified RNAi-enhancing muta-
tions exist in the rrf-1 mutant, our results are consistent with the
rrf-1 strain possessing an intrinsic ability to process dsRNA in
somatic tissues, in addition to the germline.
rrf-1(pk1417) Mutants Display Elevated Expression of
Transgenic Arrays
During the course of our experiments with the daf-16p::gfp::daf-16
reporter strain, we noticed a significantly higher expression of the
transgenic array in the rrf-1(pk1417) background compared to the
wild-type background (Figure 2B and Figure S7A, B).T h i s
significant increase in GFP fluorescence is likely due to post-
translational regulation, since daf-16 mRNA levels were not
significantly elevated in rrf-1(pk1417) mutants (Figure S7C),
consistent with a previous report [24]. Notably, we also observed
significantly increased expression of GFP when driven by a seam
cell-specific promoter (Figure 3B and Figure S4C) and by the
DTC-specific lag-2 promoter (Figure S5C). These observations
suggest that the rrf-1(pk1417) mutation can cause a general increase
in the expression of transgenic arrays. However, we were not able to
detect an increase in transgene expression in rrf-1(pk1417) mutants
expressing GFP-tagged histone 2B under the germline-specific pie-1
promoter (Figure S1B), GFP::MYO-3 from the muscle-specific
myo-3 promoter (Figure S2), or GFP::LGG-1 from the lgg-1
promoter (Figure 2A and Figure S5D), suggesting that the rrf-1
mutation does not have these regulatory effects on all transgenic
arrays.
The Expression of DAF-16/FOXO Target Gene sod-3 is
Elevated in rrf-1(pk1417) Mutants
The FOXO transcription factor DAF-16 plays a major role in
modulating longevity in C. elegans, most notably through the
insulin/IGF-1 signaling pathway [21]. This is likely achieved by
the DAF-16–dependent expression of several genes involved in
critical biological processes, including stress resistance, metabo-
lism, and disease pathogenesis [21,22,23]. Since DAF-16 plays a
prominent role in longevity modulation, we investigated the role of
rrf-1 on daf-16/FOXO in more detail. Since we found that the
rrf-1(pk1417) mutation had no effect on daf-16 mRNA levels
(Figure S7C), we asked if rrf-1 mutations affect DAF-16 activity.
Superoxide dismutase sod-3 is a DAF-16 target gene that is often
used as a measure of transcriptional activation of DAF-16 [22,25].
We compared the expression of endogenous sod-3 levels in wild-
type animals and in rrf-1(pk1417) mutants by qPCR and
unexpectedly, we observed significantly elevated sod-3 mRNA
levels in rrf-1(pk1417) mutants compared to wild-type animals
(Figure 4A). Similarly, we found that rrf-1(pk1417) mutants
displayed increased expression of a sod-3p::gfp transcriptional
reporter (Figure S7D, E). While we recognize that the
rrf-1(pk1417) mutation could directly affect expression of the
transgene, as noted above, this result is consistent with the qPCR
data measuring endogenous sod-3 levels. Because DAF-16 is a
major transcriptional regulator of sod-3 expression in C. elegans,
these observations raise the possibility that DAF-16 activity is
elevated in rrf-1 mutants.
rrf-1(pk1417) Mutants do not show Extended Lifespan or
Increased Thermo-tolerance
Increased DAF-16 activity has been associated with longevity in
animals with reduced levels of the insulin/IGF-1 like receptor
DAF-2 [21,26]. daf-2 mutants are long-lived and resistant to
various stressors, such as heat and oxidative stress [21,26]. Since
DAF-16 activity may be increased in rrf-1 mutants, we examined
whether rrf-1 mutations extend lifespan and promote stress
resistance in rrf-1 animals. However, we found no difference
between rrf-1(pk1417) mutants and wild-type animals in their
mean lifespan (Figure 4B and Figure S7) or their ability to
withstand elevated temperature (Figure 4C). Thus, although rrf-1
mutants display increased sod-3 transcript levels, indicative of
elevated DAF-16 activity, these alterations were not sufficient to
increase longevity or stress resistance in rrf-1 mutants.
Discussion
Here, we have shown that C. elegans rrf-1 mutants are capable of
processing RNAi targeting several genes expressed in the soma
(summarized in Table 1).
The strongest phenotypic effects were achieved by reducing
genes expressed in the intestine. We observed that two different
GFP transgenes expressed in the intestine were reduced in
Somatic RNAi Effects in C. elegans rrf-1 Mutants
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we found that RNAi of two endogenous targets, elt-2 and pept-1,
induced robust phenotypes in two different rrf-1 mutants. While
elt-2 RNAi seemed to play an exclusively intestinal-specific role,
pept-1 RNAi induced effects in both intestinally and hypodermally
rescued rde-1 strains [12,13]. This result may indicate that pept-1
functions as an oligopeptide transporter not only in the intestine,
but also in the hypodermis. Alternatively, we note the possibility
that the rescued rde-1 strains are not as specific in their RNAi
sensitivity as anticipated.
We also observed RNAi-processing capabilities in another
somatic tissue, the hypodermis, albeit to a limited extend. We
found that rrf-1 mutants expressing a transgenic reporter in a
specific subset of hypodermal cells, i.e., the seam cells were
susceptible to knockdown of gfp. In contrast, rrf-1 mutants failed to
respond to RNAi against bli-3 or tsp-15, which are both genes
reported to be expressed exclusively in the hypodermis. Moreover,
we found that RNAi against additional genes with hypodermal
expression (bli-4 and die-1) induced similar phenotypes in both
wild-type animals and rrf-1 mutants. While the phenotypes
induced by bli-4 and die-1 RNAi in rrf-1 mutants could originate
from the knockdown of these genes in other somatic tissues,
including the intestine (Table 1), it seems that the hypodermis of
rrf-1 mutants is not generally capable of processing dsRNA
triggers. Instead, our findings suggest that either a restricted subset
of cell types in the hypodermis of rrf-1 mutants is capable of
processing RNAi, or perhaps only some endogenous targets can be
degraded. Further analysis of endogenous targets, especially
expressed in hypodermal seam cells is warranted to address this
possibility.
Taken together, our analysis indicates that rrf-1 mutants can
process RNAi in the soma, most notably in the intestine,
demonstrating that rrf-1 mutants have broad RNAi-processing
capabilities. Consistent with this notion, new information on the
expression pattern of the predominantly germline-specific genes
pos-1, par-1 and pop-1 originally tested by Sijen et al. [7], suggests
that these genes are also expressed in somatic tissues [27,28,29,30],
which further corroborates an RNAi-processing role in the soma
of rrf-1 mutants.
These findings have important implications for the use of this
strain in tissue-specific RNAi studies, as well as for the
interpretation of published reports using RNAi in this strain.
Our literature search revealed that close to 50 studies used the
rrf-1(pk1417) mutant to investigate the role of a gene of interest in
the germline versus somatic tissues. However, several of these
publications used additional and alternative methods to confirm a
germline requirement for the gene of interest, such as mosaic
analysis [31,32,33,34,35]. Indeed, most of the published studies
used rrf-1(pk1417) mutants to determine if a gene expressed in the
gonad has a specific role in the germline or the somatic gonad
[36,37,38]. Our studies indicated that the rrf-1 mutant is resistant
to RNAi in the somatic gonad by using two different gfp-tagged
reporters. Specifically, we found that the GFP signal was
maintained in the vulva and spermatheca of an rrf-1;
lgg-1p::gfp::lgg-1 reporter strain, as well as in distal tip cells of an
rrf-1; lag-2p::gfp reporter strain (Table 1). Ideally, these experi-
ments should be complemented by an analysis of endogenous
genes; however, we have been unsuccessful in inducing phenotypes
in wild-type animals using RNAi against the endogenous genes we
investigated, including lag-2 (data not shown). Based on our results,
the rrf-1 strain may thus be a useful tool for determining a
differential requirement for a gene in the germline and somatic
gonad.
RRF-1 is one of two RdRPs involved in the exogenous siRNA
pathway that amplifies dsRNA triggers, and has been reported to
act in the soma of C. elegans [7]. In contrast, the second RdRP,
EGO-1, is thought to be required for processing of siRNA
targeting germline-specific genes [6]. Our observation that the
rrf-1 mutant is capable of processing RNAi in somatic tissues could
suggest the existence of unidentified enzymes that have overlap-
ping functions with RRF-1, or suggest a role for EGO-1 outside of
the germline. Although Smardon et al. have reported that EGO-1
Figure 4. rrf-1 mutants have increased sod-3 mRNA levels, a
normal lifespan, and normal thermo-tolerance. (A) The sod-
3 mRNA levels of a mixed population of C. elegans wild-type (WT, N2(A))
and rrf-1(pk1417).4x (rrf-1(pk1417) mutant outcrossed four times to
WT(A)) strains were determined. Bars show the mean + SEM of three
independent experiments; **P,0.005 (Student’s t-test). (B) Lifespan
analysis of wild-type WT(A) and rrf-1(pk1417).4x strains at 20uC; P=0.59,
log-rank (Mantel-Cox test). This experiment has been performed three
times with similar results; see Figure S7F for additional data. (C)
Thermo-tolerance was measured by assessing survival of WT(A) and rrf-
1(pk1417).4x strains after 8 h incubation at 36uC; P=0.36 (Student’s t-
test). This experiment has been performed three times with similar
results.
doi:10.1371/journal.pone.0035428.g004
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expressed in somatic tissues. Moreover, germline EGO-1 activity
may be sufficient to produce enough siRNA to affect other tissues.
Alternatively, RRF-2 or an unidentified RdRP may play roles in
processing RNAi in the absence of RRF-1.
One of the striking features of RNAi in C. elegans is its systemic
nature, in which the dsRNA spreads from the tissue of uptake,
most often the intestine, into other tissues [39,40,41,42]. In our
experiments, the dsRNA trigger was delivered by feeding the
animals bacteria expressing dsRNA. Therefore, it is possible that
sufficient dsRNA was ingested to at least partially knock down the
targeted mRNA in the intestine without the need for an RdRP-
mediated amplification reaction, making the mechanism RdRP-
independent. This may also be the case for the worm pharynx,
which processes bacteria upon intake. Although we have
attempted to directly address a role for the pharynx using
endogenous genes as RNAi targets, these experiments have been
hampered by the apparent refractory nature of the pharynx to
RNAi (see Figure 2A, and data not shown). While our objective
in this study was to characterize the rrf-1 strain for processing of
RNAi delivered by feeding, future studies should determine if
direct injection of the dsRNA into the germline have the same
effect on somatic gene expression of rrf-1 mutants, including in the
intestine. Perhaps direct delivery of dsRNA to the germline would
reduce exposure of the intestine and other tissues to dsRNA and
might even prevent the degradation of mRNAs encoded by
intestinal-specific genes. These additional tissues may include ones
we have not yet assayed, for example neurons, which are generally
considered refractory to RNAi by feeding [43,44].
Unexpectedly, we observed that rrf-1 mutants displayed
increased expression of an important target gene of the FOXO
transcription factor DAF-16, the superoxide dismutase SOD-3.
Since DAF-16 is a major regulator of sod-3, this observation raises
the possibility that rrf-1 mutants have increased activity of DAF-
16. DAF-16 activity is required for the extended longevity of many
C. elegans mutants, including daf-2 mutants [21]. In daf-2 mutants,
these phenotypes are mediated by nuclear translocation and
activation of DAF-16, which in turn causes upregulation of target
genes such as sod-3. We did not, however, observe nuclear
localization of DAF-16 in the rrf-1 background (Figure 2A and




targeted by RNAi Reported tissue of expression RNAi phenotype
wild-type rrf-1 Observed Citatio n
1
Germline gld-1 Germline + + Pro, Tum [52]
pie-1p::gfp::H2B Germline + + GFP loss [53]
Muscle unc-22 Muscle + 2 Unc/Twitcher [39]
pat-4 Body-wall muscle, spermatheca, DTC, vulval and anal sphincter
muscle, mechanosensory neurons
+ 2 Prz [54]
unc-112 Body-wall, vulval, spermathecal, uterine, and anal sphincter/
depressor muscles
+ 2 Prz [55]
myo-3p::gfp::myo-3 Body-wall muscle + 2 GFP loss [56]
Intestine elt-2 Intestine + + Gob, Clr, Lva [10]
pept-1 Intestine + + Clr, Gro [14]
bli-4 Hypodermis, intestine, vulva, ventral nerve cords + + Bli, Dpy [28,57]
daf-16p::gfp::daf-16
2 Intestine, hypodermis, gonad, body-wall muscles, neurons + + GFP loss [58]
lgg-1p::gfp::lgg-1
3 Intestine, hypodermis, pharynx, gonad, neurons, body-wall
muscles
+ + GFP loss [16]
Hypodermis bli-3 Hypodermis + - Bli, Dpy [18]
tsp-15
4 Hypodermis + - Bli, Dpy [19]
bli-4 Hypodermis, intestine, vulva, ventral nerve cords + + Bli, Dpy [28,57]





SCMp::gfp Seam cells + +/2
6 GFP loss [60]
Somatic gonad lag-2p::gfp Distal tip cell + 2 GFP loss [61]
lgg-1p::gfp::lgg-1 Intestine, hypodermis, pharynx, gonad, neurons, body-wall
muscles
+ 2 GFP loss [16]
‘+’a n d‘ 2’ refer to the presence or absence of a phenotype in response to RNAi treatment in wild-type or rrf-1 animals. The rrf-1(pk1417), rrf-1(pk1417).4x (rrf-1(pk1417)
four times outcrossed to WT(A) and rrf-1(ok589) mutants behaved similarly to RNAi targeting endogenous genes and are combined here as rrf-1. For strains expressing
GFP-tagged transgenes, loss of GFP expression was assayed in response to gfp RNAi in the rrf-1(pk1417) mutant only.
Phenotype abbreviations: Pro: proximal germ cell proliferation abnormal; Tum: tumorous germline; Prz: paralyzed, Unc/Twitcher: uncoordinated, sub-class, Twitcher;
Gob: gut-obstructed; Clr: clear; Lva: larval arrest; Gro: slow growth; Ste: sterile; Bli: blistered; Dpy: dumpy; Bmd: body morphology defects; DTC: distal tip cell.
1Citations refer to studies describing expression patterns and gene functions of the genes targeted by RNAi and to descriptions of the transgenes used;
2Only the intestinal expression of daf-16p::gfp::daf-16 was examined;
3The intestinal, pharyngeal, and gonadal expression of lgg-1p::gfp::lgg-1 was examined;
4Data not shown;
5RNAi phenotypes observed in 2
nd generation;
6Transgene expression was only partially reduced.
doi:10.1371/journal.pone.0035428.t001
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increase in longevity or thermo-tolerance in the rrf-1(pk1417)
mutant, suggesting that if rrf-1 mutants have increased DAF-16
activity, it is not sufficient to extend lifespan. This would be
consistent with the observation that increased expression of SOD-
3 does not extend C. elegans lifespan [45]. It remains to be explored
how inhibition of the RdRP rrf-1 leads to increased expression of
SOD-3, and whether other DAF-16 targets are similarly affected.
Regardless of the exact mechanism, our novel findings that rrf-1
mutants show efficient RNAi in somatic tissues and also exhibit
increased expression of the DAF-16-regulated stress response gene
sod-3, should be considered before using these mutants in tissue-
specific RNAi studies, especially in the study of longevity pathways
with relevance to the FOXO transcription factor DAF-16.
In addition to observing a new somatic RNAi-processing
ability and increased expression of endogenous sod-3, we also
noted that multiple, but not all, transgenes used in our
investigation were expressed at higher levels in rrf-1 mutants.
These observations suggest that RRF-1 can negatively regulate
transgene expression, at least in some cases. Notably, we
observed no direct correlation between the tissues in which
transgenic expression was increased by rrf-1 mutation and the cell
types that responded to RNAi processing. Moreover, the
daf-16p::gfp::daf-16 and lgg-1p::gfp::lgg-1 reporters both responded
to gfp RNAi in the intestine when expressed in rrf-1 mutants, but
only the daf-16p::gfp::daf-16 reporter was notably upregulated by
the rrf-1 mutation. This suggests that the mechanism regulating
transgene expression in rrf-1 mutants is not identical to that of
RNAi processing. While the mechanism of transgene regulation
is currently unclear, it is an important result because the
increased expression of specific transgenes in rrf-1 mutants could
induce morphological or cellular changes. Indeed, rrf-1 mutants
may display many more phenotypes than noted previously or
reported here, and this information should be kept in mind when
using this mutant as a tool for studying gene function.
Materials and Methods
Strains and Culture Conditions
Strains were maintained and cultured under standard condi-
tions at 20uC using E. coli OP50 as a food source [46], except when
subjected to RNAi treatment. We used these previously reported
strains in this study (see Table 1 for references):
WT(A): Hansen-lab N2, WT(B): Tuck-lab N2 (Simon Tuck,
University of Umea ˚), NL2098: rrf-1(pk1417) I, RB798:
rrf-1(ok589) I, NL2099: rrf-3(pk1426) II,
WM27: rde-1(ne219) V,
VP303: rde-1(ne219) V; kbIs7[nhx-2p::rde-1 + rol-6(su1006)],
NR222: rde-1(ne219) V; kbIs9[lin-26p::nls::gfp, lin-26p::rde-1 +
rol-6(su1006)],
DA2123: adIs2122[lgg-1p::gfp::lgg-1 + rol-6(su1006)],
CF1934: daf-16(mu86) I; muIs109[daf-16p::gfp::daf-16 +
odr-1p::rfp],
AZ212: unc-119(ed3) III; ruIs32[unc-119(+) pie-1(+)
pie-1p::gfp::H2B],
RW1596: myo-3(st386) V; stEx30[myo-3p::gfp::myo-3 +
rol-6(su1006)],
CF1553: muIs84[sod-3p::gfp],
JK2049: qIs19[lag-2p::gfp + rol-6(su1006)] V,
JR667: unc-119(e2498::Tc1) III; wIs51[SCMp::gfp + unc-119].
We note that the promoter of the seam-cell marker (SCM) used
for GFP expression in the JR667 strain has not been reported.
We created the following new strains for this study:
MAH19: rrf-1(pk1417) I, myo-3(st386)V; stEx30[myo-3p::gfp::
myo-3 + rol-6(su1006)],
MAH22: rrf-1(pk1417) I; adIs2122[lgg-1p::gfp::lgg-1 +
rol-6(su1006)],
MAH23: rrf-1(pk1417) I outcrossed 4 times to Hansen-lab N2
and referred to as rrf-1(pk1417).4x,
MAH74: rrf-1(pk1417) I; unc-119(ed3) III; ruIs32[unc-119(+)
pie-1(+) pie-1p::gfp::H2B],
MAH97: rrf-1(pk1417) I; muIs109[daf-16p::gfp::daf-16 +
odr-1p::rfp],
MAH99: rrf-1(pk1417) I; muIs84 [sod-3p::gfp],
MAH132: rrf-1(k1417) I; unc-119(e2498::Tc1) III;
wIs51[SCMp::gfp + unc-119],
MAH133: rrf-1(pk1417) I; qIs19[lag-2p::gfp + rol-6(su1006)] V.
We note that we observed germline defects in 5–10% of the
assayed animals of the rrf-1(pk1417); lag-2p::gfp strain (data not
shown), whereas no defects were observed when this transgene was
expressed in the wild-type background, or in the rrf-1(pk1417)
mutant without expression of the lag-2p::gfp reporter, or in the
rrf-1(pk1417); pie-1p::gfp::H2B strain (data not shown).
RNAi Treatment and Imaging
The gfp RNAi clone was obtained from Dr. Andrew Dillin (Salk
Institute). The bli-4 and elt-2 clones used were obtained from the
Vidal RNAi library [47]; the elt-2, pept-1, pat-4, unc-112, pha-4,
gld-1 and bli-3 RNAi clones were obtained from the Ahringer
library [48]. All RNAi clones were verified by sequencing. For the
RNAi treatment, worms were synchronized by hypochlorous acid
treatment and the eggs seeded on the NGM plates with bacteria
expressing the dsRNA. Differential interference contrast (DIC)
microscopy was performed on a Zeiss Imager Z1 after mounting
worms on a 2% agarose pad containing 0.1% NaN3,i nM 9
medium also containing 0.1% NaN3. Worms on plates were
imaged on plates with a Leica DFC310 FX camera. For the
analysis of GFP expression, fluorescence images were collected on
a Zeiss Imager Z1 at the exposure times indicated in the figure
legends. Image analysis was performed with ImageJ software
(National Institutes of Health), by tracing the intestine (for strains
expressing daf-16p::gfp::daf-16 and sod-3p::gfp) or the entire worm
(lgg-1p::gfp::lgg-1 expressing strains) and measuring the integrated
density. The analysis of strains expressing lag-2p::gfp was performed
by tracing a defined circular DTC-encompassing region of interest
and measuring the mean density. For the analysis of the GFP
intensity of the seam cells, 1–5 regions of interest encompassing
2360 pixels were drawn around the single seam cell bodies and the
average mean density per worm was calculated. For the analysis of
the germline overproliferation following gld-1 RNAi treatment,
worms were washed off the plates on day 3 of adulthood and
washed three times in M9 media before fixing in methanol
overnight at -20uC. For DAPI staining, methanol was removed by
washing with M9 media, 0.1 mg/ml DAPI in M9 was added, and
samples were incubated for 20 min on a slow nutator. Worms
were washed with M9 and then mounted on agarose pads for
imaging. Statistical analyses were performed by Student’s t-test
and two-way ANOVA using GraphPad Prism (La Jolla, CA). If
RNAi was induced for a second generation, the eggs of the first
generation of animals were transferred to new RNAi plates and
these animals were then scored. All experiments were carried out
at 20uC.
Quantitative RT-PCR
The graphs show the average from three biological replicates
(with three technical replicates). For each experiment, total RNA
was isolated from a mixed population of ,2000 nematodes that
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Trizol (Life Technologies, Grand Island, NY) and purified using
the Qiagen RNeasy kit (Valencia, CA), including an additional
DNA digest step using the Qiagen Dnase I kit. The M-MuLV
reverse transcriptase and random 9-mer primers (New England
Biolabs, Ipswich, MA) were used for reverse transcription of 1 mg
of RNA per sample [49]. Quantitative PCR was run using SYBR
Green Master Mix in a Roche LC480 LightCycler (Indianapolis,
IN). A standard curve was run for each primer on serial dilutions
of a mixture of different cDNAs, and the observed CT values
were converted to relative values according to the primers’
standard curves. The mRNA levels of target genes were
normalized to those of the housekeeping genes cyclophilin (cyn-
1) and nuclear hormone receptor nhr-23. Primer information is
available upon request.
Lifespan Analysis
Lifespan was measured at 20uC with at least 90 worms in each
experiment [50]. Animals were scored as dead when they failed to
respond to gentle prodding with a platinum wire pick. Censoring
occurred if animals desiccated on the edge of the plate, escaped,
ruptured, or suffered from internal hatching. For statistical analysis
Stata software was used (StataCorp, College Station, TX). P values
were calculated with the log-rank (Mantel-Cox) method.
Thermo-tolerance Assay
The survival of C. elegans at elevated temperatures was measured
after an 8 h incubation at 36uC [51]. The synchronized wild-type
and rrf-1(pk1417) animals were transferred to assay plates on day 1
of adulthood and the thermo-tolerance experiment was performed
on day 3 of adulthood. This experiment was performed at least
3 times with similar results. Student’s t-test was used to calculate
P values.
PCR Assay for eri-6/7 Mutations and Genomic
Rearrangement
Single worms were used in these PCR assays. Worms were lysed
in 10 ml proteinase K buffer (1 mg/ml proteinase K, 1x PCR buffer,
H2O) at 65uC for 1 h and 95uC for 15 min. Taq polymerase was
used to amplify the PCR product for 35 cycles with an annealing
temperature of 58uC. Primer sequences were: P1 (MH439): 59-
GCCAGTGCTTCACGTGTC-39, P2 (MH440): 59-CGAAGCC-
CAGATGTGAGATC-39 P3 (MH479): 59-TAAGTTTTCC-
TAAAATGATTTC-39. This protocol was adapted from [4].
Supporting Information
Figure S1 rrf-1 mutants are capable of processing RNAi
in the germline. (A) The indicated C. elegans strains were raised
on bacteria expressing gld-1 dsRNA, fixed in methanol on day 3 of
adulthood, and subsequently stained with DAPI and imaged by
fluorescence microscopy. All strains display mitotic germ cell
overproliferation except the RNAi-resistant rde-1 strain, which
shows typical mitotic and meiotic zones in the distal end of the
gonad, and eggs in utero in the proximal part of the gonad. This
experiment was repeated twice with 50–100 worms per strain with
similar results. WT: wild-type N2 (A – Hansen lab, B – Tuck lab),
rrf-1(pk1417).4x: rrf-1(pk1417) outcrossed 4 times to WT(A). (B)
The indicated C. elegans strains were raised on bacteria expressing
gfp dsRNA and imaged by DIC and fluorescence microscopy
(overlays shown here) on day 1 of adulthood. rrf-1 mutants carried
the pk1417 allele. The pie-1p::gfp::H2B reporter is expressed in the
germline of C. elegans. GFP expression is completely abolished
upon treatment with gfp RNAi, in both the wild-type and rrf-1
backgrounds. The image shows one arm of the gonad including
oocytes, and was acquired with an exposure time of 100 ms. This
experiment was repeated twice with 30–50 worms per strain and
imaging of ,10 per experiment, with similar results.
(TIF)
Figure S2 rrf-1 mutants are resistant to RNAi in the
muscle. (A) The indicated C. elegans strains were raised on
bacteria expressing gfp dsRNA, and imaged by fluorescence
microscopy on day 1 of adulthood. rrf-1 mutants carried the
pk1417 allele. The body-wall muscle-specific GFP expression is
maintained in the rrf-1 background, but completely abolished in
the wild-type background. The exposure time for the GFP channel
was 200 ms. This experiment was repeated twice with similar
results. (B) The indicated C. elegans strains were raised from
hatching on bacteria expressing muscle-specific unc-112, pat-4, and
unc-22 RNAi and were assayed for paralysis and twitching on day
1 of adulthood. The experiments have been repeated at least two
times with similar results. WT: wild-type N2 (A – Hansen lab, B –
Tuck lab), rrf-1(pk1417).4x: rrf-1(pk1417) outcrossed 4 times to
WT(A). Phenotype abbreviations: Prz: paralyzed; Unc: uncoordi-
nated, sub-class, Twitcher. n.a.: not assayed.
(TIF)
Figure S3 Intestinal pept-1 RNAi induces phenotypes in
rrf-1 mutants. The indicated C. elegans strains were raised on
bacteria expressing pept-1 dsRNA, and imaged by bright-field
microscopy on day 1 of adulthood. WT: wild-type N2 (A – Hansen
lab, B – Tuck lab), rrf-1(pk1417).4x: rrf-1(pk1417) outcrossed 4
times to WT(A). (A) The rrf-1 animals were smaller and have a
clear appearance, whereas the wild-type and hypersensitive RNAi
strain rrf-3 were developmentally delayed. (B) Quantification of
the mid-body diameter of all the strains shows that all strains are
significantly smaller than the unaffected rde-1 strain. This
experiment has been repeated three times with similar results.
Size quantification was determined with 7–10 worms per strain.
Bars show the mean + SEM of one representative experiment.
P,0.0001 was determined with one-way ANOVA, and individual
significance was determined with Bonferroni’s multiple compar-
ison test: **P,0.005 ***P,0.0005.
(TIF)
Figure S4 rrf-1 mutants are partially affected by RNAi
targeting the hypodermis. (A) The indicated C. elegans strains
were raised on bacteria expressing bli-3 (expressed in the
hypodermis), bli-4 (expressed in the hypodermis, intestine, vulva,
and ventral nerve cords) or die-1 (expressed embryonically in the
hypodermis, pharyngeal cells, and muscle/gut primordium precur-
sor cells) RNAi from hatching. Worms were assayed for the
indicated phenotypes on day 1 of adulthood of the first generation
for bli-3 and bli-4 RNAi and the second generation of RNAi
treatment for die-1 RNAi. These assays have been repeated two or
three times with similar results. WT: wild-type N2 (A – Hansen lab,
B – Tuck lab), rrf-1(pk1417).4x: rrf-1(pk1417) outcrossed 4 times to
WT(A). Phenotype abbreviations: Bli: blistered cuticle; Bmd: body
morphology defects. n.a.: not assayed in this experiment, but these
strains showed no effect when ,10 worms were imaged in a
separate experiment (data not shown). {: phenotypes only observed
in 2nd generation of RNAi treatment. (B) The indicated C. elegans
strains were raised on bacteria expressing bli-4 dsRNA, and imaged
by bright-field microscopy on day 1 of adulthood. The gene bli-4 is
expressed in the hypodermis, intestine, vulva, and ventral nerve
cords. All strains except the RNAi-resistant rde-1(ne219) strain were
affected by the RNAi treatment.This experiment hasbeen repeated
twice with similar results. (C) Quantification of the fluorescence
intensity of wild-type and rrf-1(pk1417) animals expressing
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images of one representative experiment (Figure 3B). Because the
transgene expression in the rrf-1 strain background was greatly
increased compared to the wild-type animals, the exposure times
were 5 ms and 100 ms, respectively. Student’s t-test was performed
for statistical analysis: *P,0.05, ***P,0.0005.
(TIF)
Figure S5 rrf-1 mutants are inefficient in processing gfp
RNAi in the somatic gonad. The indicated C. elegans strains
were raised on bacteria expressing gfp dsRNA, and imaged by DIC
and fluorescence microscopy (overlays shown here) on day 1 of
adulthood. rrf-1 mutants carried the pk1417 allele. (A) The
lag-2p::gfp reporter is expressed solely in the distal tip cell (DTC)
of C. elegans. GFP expression in this strain was dramatically
reduced upon treatment with gfp RNAi, whereas the rrf-1 mutant
maintained DTC fluorescence. DTCs are indicated by arrows.
Asterisk denotes the DTC from the opposite gonad arm, which is
out of focus in this image. The exposure time for the GFP channel
was 100 ms. (B) The lgg-1p::gfp::lgg-1 reporter is expressed in the
intestine, pharynx, somatic gonad, and hypodermis. GFP
expression in this strain was dramatically reduced upon treatment
with gfp RNAi. The rrf-1 mutant lost all intestinal GFP
fluorescence but maintained GFP in the spermatheca (SP) and
vulva. The spermatheca is indicated by an arrow. The exposure
time for the GFP channel was 5 ms. (C) Quantification of the
fluorescence intensity of animals expressing lag-2p::gfp raised on
OP50 bacteria from images of one representative experiment.
Student’s t-test was performed for statistical analysis: **P,0.005
(similar results were obtained when empty-vector control bacteria
were used as the control condition, data not shown). The GFP
intensity of the rrf-1 strain is under-represented due to saturation of
the GFP level. This experiment was repeated twice with similar
results. (D) Quantification of the fluorescence intensity of images of
whole animals expressing lgg-1p::gfp::lgg-1 raised on OP50 bacteria
from images of one representative experiment. Student’s t-test was
performed for statistical analysis: n.s., P.0.05 (similar results were
obtained when empty-vector control bacteria were used as the
control condition, data not shown). This experiment was repeated
three times with similar results (See also Figure 2A).
(TIF)
Figure S6 rrf-1 mutants do not show deletions or
genomic rearrangements in the eri-6/eri-7 gene locus.
Image of an ethidium-bromide stained agarose gel after electro-
phoresis of PCR-amplified DNA of the indicated C. elegans strains,
with primer combination P1 + P2 or P1 + P3. In wild-type animals
the genes eri-6 and eri-7 are in the trans position, and eri-6 is flanked
by direct repeats (indicated by blue arrows). Mutation mg441
induces the inversion of the direct repeats, which leads to a
genomic rearrangement of eri-6 into the cis position. The assay was
designed to detect a possible genomic rearrangement as indicated
by the presence of an amplification product with primer pair
P1 + P3 instead of P1 + P2. PCR with P1 + P2 of all strains
resulted in the same size amplification product, indicating that
none of the strains carries a deletion mutation at this gene locus.
WT: wild-type N2 (A – Hansen lab, B – Tuck lab),
rrf-1(pk1417).4x: rrf-1(pk1417) outcrossed 4 times to WT(A).
(TIF)
Figure S7 rrf-1 mutants display no increase in daf-
16 mRNA levels, but increased transgenic expression of
the daf-16 target gene sod-3. (A) The indicated C. elegans
strains were raised on OP50 bacteria and imaged by bright-field
and fluorescence microscopy (overlays shown here) on day 1 of
adulthood. rrf-1(pk1417) mutants have increased GFP expression
as shown in representative images. The exposure time for the GFP
channel was 200 ms. (B) Quantification of the intestinal
fluorescence intensity of animals expressing daf-16p::gfp::daf-16
from images of one representative experiment. Student’s t-test was
performed for statistical analysis: ***P,0.0005. This experiment
has been repeated three times with similar results (see also
Figure 2B). (C) The daf-16 mRNA levels of a mixed population
of wild-type (WT, N2(A)), rrf-1(pk1417).4x (rrf-1(pk1417) mutant
outcrossed four times to N2(A)), and the reporter strains expressing
daf-16p::gfp::daf-16 and rrf-1; daf-16p::gfp::daf-16 were determined.
Bars show the mean + SEM of three independent experiments;
n.s.: P.0.05 (one-way ANOVA). (D) The indicated C. elegans
strains were raised on OP50 bacteria and imaged on day 3 of
adulthood. rrf-1 mutants have increased GFP expression as shown
in representative images. The exposure time for the GFP channel
was 200 ms. (E) Quantification of the intestinal fluorescence
intensity of animals expressing sod-3p::gfp from images of one
representative experiment. Student’s t-test was performed for
statistical analysis: ***P,0.0005. This experiment has been
repeated three times with similar results. (F) Three independent
lifespan experiments comparing wild-type (WT(A): N2 from the
Hansen lab) to rrf-1(pk1417).4x animals (rrf-1(pk1417) mutant
outcrossed 4 times to N2(A)) were performed at 20uC using OP50
bacteria as the food source. MLS: mean lifespan; N: population
number; P-value obtained with Mantel-Cox log-rank test.
(TIF)
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